CPT code 86807: Transplant antibody screen, standard cytotoxicity method2026 Medicare lab fee · Clinical Laboratory Fee Schedule

Measures serum cytotoxic antibodies associated with transplant sensitization using the standard method, commonly during transplant evaluation or monitoring.

CMS CLFS 2026 Q4Effective Oct 1, 2026Same amount nationwide75 Medicare services in 2024

Medicare pays $78.65 for 86807 under the 2026 Clinical Laboratory Fee Schedule: one national amount, the same in every state and setting.

Medicare lab fee · CLFS 2026 Q4

National CLFS amount

$78.65

In effect since Jan 1, 2026. The same amount in every state, payment locality and setting.

Geographic adjustment
None
Office vs facility
Same
Since 2020
Unchanged
CMS updates
Quarterly

Medicare pays the lesser of the lab’s charge and this amount. Patients usually owe no Part B deductible or coinsurance for covered clinical lab tests.

On this page 8 sections
  1. Medicare lab fee
  2. What 86807 covers
  3. How it’s paid
  4. Amount history
  5. Similar tests
  6. Related codes
  7. Billing questions
  8. Sources

What 86807 covers

This laboratory test measures serum cytotoxic antibodies relevant to transplantation using a standard method. It supports assessment of transplant-related sensitization. Histocompatibility laboratories perform the assay as part of transplant evaluation or monitoring; the reported service is antibody screening, not a donor-specific compatibility crossmatch. The method distinguishes 86807 from the related screening code 86808, which uses flow cytometry.

Medicare pays this test under the CLFS at one national amount across states and localities, without geographic or office-versus-facility adjustment. The 2026 national CLFS amount is $78.65, unchanged from 2020 through 2026. The test is paid through the CLFS rather than the physician fee schedule.

This summary was written with AI assistance from CMS Clinical Laboratory Fee Schedule data. Amounts on this page come directly from CMS files.

How Medicare pays 86807

Clinical lab tests aren’t priced like physician services. They’re paid from their own fee schedule, with its own rules. See the whole lab fee schedule.

One national amount

CMS sets a single Clinical Laboratory Fee Schedule amount for 86807. There’s no geographic (GPCI) adjustment, so it pays the same in every state and payment locality.

No office or facility rate

Lab tests aren’t built from relative value units, so there’s no office and facility split: the place of service doesn’t change the CLFS amount.

Updated every quarter

CMS republishes the CLFS each quarter. New tests, often proprietary laboratory analyses (PLA codes), join during the year; existing amounts are updated each January.

Excluded from the physician fee schedule

The physician fee schedule lists 86807 with status X (excluded by statute), so the test itself is paid only from the CLFS.

86807 on the lab fee schedule since 2020

86807 · CLFS 2026 Q4 (current)

$78.65

Unchanged since Jan 1, 2020

Amount in each year’s latest CLFS release · bars start at $0

27 quarterly CLFS releases on file, first CLFS 2020 Q1. A code missing from a quarter wasn’t on that release.

86807 compared with similar tests

86808Transplant antibody screenQuick screening method$29.68
Both screen serum for cytotoxic antibodies relevant to transplantation. Choose 86807 for the standard method and 86808 for flow cytometry.
86828HLA antibodiesBoth HLA classes$64.19
Code 86807 is a standard-method cytotoxic antibody screen; 86828 is qualitative HLA class I and II antibody testing.
86825HLA crossmatchFirst serum sample or dilution$109.49
Code 86807 screens serum for cytotoxic antibodies. Code 86825 is a non-cytotoxic HLA crossmatch that assesses a specific donor-recipient pairing.

86807 billing questions

When should the standard-method code be used instead of 86808?

Use 86807 for the standard cytotoxicity method. Code 86808 is the related cytotoxic antibody screening code for the flow cytometry method.

Is this the same as an HLA crossmatch?

No. This code screens serum for cytotoxic antibodies; an HLA crossmatch evaluates compatibility between a recipient and a specific donor.

Does Medicare pay this test under the physician fee schedule?

No. Medicare pays it only under the CLFS, using one national amount across localities and without an office-versus-facility difference.

What documentation supports reporting this code?

Document the serum tested, the standard cytotoxicity method, and the transplant-related clinical purpose for antibody screening.

Where this amount comes from

FeeBase reads lab amounts directly from the CMS Clinical Laboratory Fee Schedule file for the quarter: one row per code, with its payment indicator and national amount. Contractor-priced tests are labeled, never given a made-up amount. Amounts are Medicare payment limits, not a patient’s bill or a commercial rate.

CMS CLFS 2026 Q4 · effective Oct 1, 2026 through the day before Jan 1, 2027

Show the CMS file line behind this amount
CLFS row for 86807PUF_CLFS_CY2026_Q4V1.csv, line 1,830 (CLFS 2026 Q4)

Open CMS sourceHow we source rates

Did this answer your question about what Medicare pays for 86807?

Tell us what you were actually trying to work out. We’ll answer you directly, or build the page that does.

Fee sheets · Coming soon

Put 86807 and the rest of your codes on one sheet

Your codes at your locality, with payer contracts beside Medicare.

Join the waitlist